Publication Name	世界华人消化杂志
手稿编号	39546
手稿来源省、自治区或特别行政区	浙江省

Received	2023-07-03 01:01
Peer-Review Started	2023-07-03 02:05
To Make the First Decision
Return for Revision	2023-07-13 22:17
修回稿	2023-07-21 14:52
Second Decision	2023-08-22 14:27
期刊总编辑接受
公司总编辑接受	2023-08-24 16:30
预出版	2023-08-24 16:30
缴纳版面费
Edit the Manuscript by Language Editor
排版	2023-08-28 08:26
在线出版	2023-08-28 12:22

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化内科学
手稿栏目类型	临床实践
文章标题	参附注射液联合瑞舒伐他汀对合并冠心病胃癌手术切除患者心肌损伤及不良事件发生率的影响
手稿来源	自由来稿
所有作者列表	周威, 张占丰
基金项目及其编号
通讯作者	周威, 本科, 主治医师, 313000 , 浙江省湖州市广场后路158号，313000, 湖州市第一人民医院药剂科. thxfjb@163.com
关键词	参附注射液; 瑞舒伐他汀; 冠心病; 胃癌; 心肌损伤; 心脏不良事件
核心内容提要	参附注射液联合瑞舒伐他汀应用于冠心病胃癌手术切除患者能减轻手术应激反应, 提高手术安全性, 同时能促进术后恢复.
出版日期	2023-08-28 12:22
引文著录	周威, 张占丰. 参附注射液联合瑞舒伐他汀对合并冠心病胃癌手术切除患者心肌损伤及不良事件发生率的影响. 世界华人消化杂志 2023; 31(16): 688-694
URL	https://www.wjgnet.com/1009-3079/full/v31/i16/688.htm
DOI	https://dx.doi.org/10.11569/wcjd.v31.i16.688

Full Article (PDF)	WCJD-31-688-with-cover.pdf
补充材料	WCJD-39546-Informed consent statement.pdf
审稿意见	WCJD-39546-Peer-review(s).pdf
科学编辑工作清单	WCJD-39546-Scientific editor work list.pdf